From start to finish — one partner across the same global lab system improves efficiency.
Global Integration and Execution
Regulatory compliance
Accelerated assay development
Faster enrollment-ready decisions
Cross-validated instruments
CellCarta is the global exclusive provider of Biofidelity’s Aspyre® Lung in clinical trial settings, a multi-gene profiling panel designed to run on existing qPCR platforms. Aspyre simplifies the detection of NSCLC biomarkers for a fast turnaround in results, streamlining patient management.
